Natural history of Cirrhosis

Complications of Cirrhosis: Evaluation and Management

Volumn , Issue , 2015, Pages 13-20

  Garcia Tsao, Guadalupe ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ascites; Esophageal varices; Hepatic encephalopathy; Hepatic venous pressure gradient; MELD score; Portal hypertension

Indexed keywords

EID: 84944596357     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-13614-1_2     Document Type: Chapter

References (35)

1. Garcia-Tsao G, Friedman S, Iredale J, et al. Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis. Hepatology. 2010;51:1445-9.
2. Rosselli M, MacNaughtan J, Jalan R, et al. Beyond scoring: a modern interpretation of disease progression in chronic liver disease. Gut. 2013;62:1234-41.
3. Blasco A, Forns X, Carrion JA, et al. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology. 2006;43:492-9.
4. Nagula S, Jain D, Groszmann RJ, et al. Histologicalhemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis. J Hepatol. 2006;44:111-7.
5. Sethasine S, Jain D, Groszmann RJ, et al. Quantitative histological-hemodynamic correlations in cirrhosis. Hepatology. 2012;55:1146-53.
6. Kumar M, Sakhuja P, Kumar A, et al. Histological subclassification of cirrhosis based on histologicalhaemodynamic correlation. Aliment Pharmacol Ther. 2008;27:771-9.
7. Kim MY, Cho MY, Baik SK, et al. Histological sub-classification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension. J Hepatol. 2011;55:1004-9.
8. Manne V, Akhtar E, Saab S. Cirrhosis regression in patients with viral Hepatitis B and C: a systematic review. J Clin Gastroenterol. 2014;48(9):e76-84.
9. D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis. A systematic review of 118 studies. J Hepatol. 2006;44:217-31.
10. D’Amico G, Pasta L, Morabito A, et al. Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients. Aliment Pharmacol Ther. 2014;39:1180-93.
11. Ripoll C, Bari K, Garcia-Tsao G. Serum albumin can identify patients with compensated cirrhosis with a good prognosis. J Clin Gastroenterol. 2014 Sep 8. [Epub ahead of print]
12. Perello A, Escorsell A, Bru C, et al. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology. 1999;30:1393-7.
13. Groszmann RJ, Garcia-Tsao G, Bosch J, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353:2254-61.
14. Garcia-Tsao G, Groszmann RJ, Fisher RL, et al. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology. 1985;5:419-24.
15. Bruno S, Zuin M, Crosignani A, et al. Predicting mortality risk in patients with compensated HCV-induced cirrhosis: a long-term prospective study. Am J Gastroenterol. 2009;104:1147-58.
16. Zipprich A, Garcia-Tsao G, Rogowski S, et al. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis. Liver Int. 2012;32:1407-14.
17. Ripoll C, Groszmann R, Garcia-Tsao G, et al. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007;133:481-8.
18. Ripoll C, Groszmann RJ, Garcia-Tsao G, et al. Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosis. J Hepatol. 2009;50:923-8.
19. Lebrec D, De Fleury P, Rueff B, et al. Portal hyper-tension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology. 1980;79:1139-44.
20. Zipprich A, Seufferlein T, Dollinger MM. Subclinical ascites defines an intermediate stage between com-pensated and decompensated cirrhosis. Z Gastroenterol. 2012;50:996-1001.
21. Ferenci P, Lockwood A, Mullen KD, et al. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology. 2002;35:716-21.
22. Laleman W, Simon-Talero M, Maleux G, et al. Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a mul-ticenter survey on safety and efficacy. Hepatology. 2013;57:2448-57.
23. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology. 2006;43:S121-31.
24. Bruno S, Saibeni S, Bagnardi V, et al. Mortality risk according to different clinical characteristics of first episode of liver decompensation in cirrhotic patients: a nationwide, prospective, 3-year follow-up study in Italy. Am J Gastroenterol. 2013;108:1112-22.
25. Garcia-Tsao G, D’Amico G, Abraldes JG, Schepis F, Merli M, Kim WR, et al. Predictive models in portal hypertension. In: de Franchis R, editor. Portal hypertension IV. Proceedings of the Fourth Baveno International Consensus Workshop on Methodology of Diagnosis and Treatment. Oxford: Blackwell; 2006. pp. 47-100.
26. Wedd J, Bambha KM, Stotts M, et al. Stage of cirrhosis predicts risk of liver related death in low MELD patients with cirrhosis awaiting liver transplant. Liver Transpl. 2014;20(10):1193-201.
27. Garcia-Tsao G, Parikh CR, Viola A. Acute kidney injury in cirrhosis. Hepatology. 2008;48:2064-77.
28. Moitinho E, Escorsell A, Bandi JC, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology. 1999;117:626-31.
29. Abraldes JG, Aracil C, Catalina MV, et al. Value of HVPG predicting 5-day treatment failure in acute variceal bleeding. Comparison with clinical variables. J Hepatol. 2006;44(Suppl 2):S12 (abstract).
30. Ripoll C, Banares R, Rincon D, et al. Influence of hepatic venous pressure gradient on the prediction of survival of patients with cirrhosis in the MELD Era. Hepatology. 2005;42:793-801.
31. Salerno F, Borroni G, Moser P, et al. Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients. Am J Gastroenterol. 1993;88:514-9.
32. Kim WR, Biggins SW, Kremers WK, et al. Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med. 2008;359:1018-26.
33. Alessandria C, Ozdogan O, Guevara M, et al. MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation. Hepatology. 2005;41:1282-9.
34. Bajaj JS, O’Leary JG, Reddy KR, et al. Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures. Hepatology. 2014;60(1):250-6. doi:10.1002/hep.27077.
35. Moreau R, Jalan R, Gines P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426-37.